Commonwealth Equity Services’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $276K | Buy |
+1,143
| New | +$276K | ﹤0.01% | 3669 |
|
|
2024
Q2 | – | Sell |
-2,114
| Closed | -$731K | – | 4054 |
|
|
2024
Q1 | $731K | Buy |
+2,114
| New | +$731K | ﹤0.01% | 2484 |
|
|
2023
Q4 | – | Sell |
-674
| Closed | -$242K | – | 3916 |
|
|
2023
Q3 | $242K | Sell |
674
-47
| -7% | -$16.9K | ﹤0.01% | 3214 |
|
|
2023
Q2 | $273K | Buy |
721
+38
| +6% | +$14.4K | ﹤0.01% | 3131 |
|
|
2023
Q1 | $327 | Sell |
683
-54
| -7% | -$26 | ﹤0.01% | 2897 |
|
|
2022
Q4 | $309K | Sell |
737
-255
| -26% | -$107K | ﹤0.01% | 2843 |
|
|
2022
Q3 | $413K | Buy |
992
+21
| +2% | +$8.74K | ﹤0.01% | 2570 |
|
|
2022
Q2 | $480K | Buy |
971
+275
| +40% | +$136K | ﹤0.01% | 2434 |
|
|
2022
Q1 | $392K | Buy |
696
+33
| +5% | +$18.6K | ﹤0.01% | 2731 |
|
|
2021
Q4 | $500K | Sell |
663
-209
| -24% | -$158K | ﹤0.01% | 2517 |
|
|
2021
Q3 | $650K | Sell |
872
-57
| -6% | -$42.5K | ﹤0.01% | 2273 |
|
|
2021
Q2 | $598K | Buy |
929
+113
| +14% | +$72.7K | ﹤0.01% | 2327 |
|
|
2021
Q1 | $466K | Sell |
816
-478
| -37% | -$273K | ﹤0.01% | 2388 |
|
|
2020
Q4 | $754K | Sell |
1,294
-548
| -30% | -$319K | ﹤0.01% | 1854 |
|
|
2020
Q3 | $949K | Buy |
1,842
+1,065
| +137% | +$549K | ﹤0.01% | 1531 |
|
|
2020
Q2 | $350K | Buy |
777
+44
| +6% | +$19.8K | ﹤0.01% | 2153 |
|
|
2020
Q1 | $256K | Sell |
733
-39
| -5% | -$13.6K | ﹤0.01% | 2184 |
|
|
2019
Q4 | $285K | Sell |
772
-4
| -0.5% | -$1.48K | ﹤0.01% | 2360 |
|
|
2019
Q3 | $258K | Buy |
+776
| New | +$258K | ﹤0.01% | 2364 |
|
|
2018
Q4 | – | Sell |
-708
| Closed | -$221K | – | 2689 |
|
|
2018
Q3 | $221K | Sell |
708
-5
| -0.7% | -$1.56K | ﹤0.01% | 2418 |
|
|
2018
Q2 | $206K | Buy |
+713
| New | +$206K | ﹤0.01% | 2438 |
|